Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Adam Blaisdell, MD, PhD
Immunotherapy has been revolutionizing cancer treatment for more than a decade. The idea for these therapies came… -
CRI Funded Scientist
Hamza Furkan Alkan, PhD
Melanoma accounts for most skin cancer-related deaths due to its highly metastatic nature. Metastasis, the spreading of… -
CRI Funded Scientist
Taishi Yonezawa, PhD
Certain somatic mutations result in clonal expansion of mutated hematopoietic cells. This phenomenon, clonal hematopoiesis (CH), accelerates… -
CRI Funded Scientist
Jianhang Yin, PhD
CD40 signaling and downstream NF-κB pathways play important roles in germinal center (GC) B cell development and… -
CRI Funded Scientist
Yun Xia, PhD
Immunotherapy has recently emerged as an effective cancer treatment modality that has improved the survival of patients… -
CRI Funded Scientist
Thornton W. Thompson, PhD
Colorectal cancer (CRC) is a major cause of morbidity and mortality worldwide. Unfortunately, recent advances in immunotherapy… -
CRI Funded Scientist
Raymond Shim, PhD
Metastasis, the spreading of cancer cells around the body, is the leading cause of cancer-related deaths. The… -
CRI Funded Scientist
Xiong Pi, PhD
B cells can recognize a large group of structurally highly diverse antigens using the membrane-bound immunoglobulin (mIg)… -
CRI Funded Scientist
Dillon G. Patterson, PhD
Immunotherapy is a cancer treatment that uses the immune system of an individual to fight cancer. Immune…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.